New Delhi[India], Nov 16 (ANI) Indian government is in dialogue with US biotech giant Moderna, regarding initial successful development of its COVID-19 vaccine candidate, which the drugmaker on Monday announced had achieved 94.5 per cent efficacy in phase 3 trials.
Washington DC [US], November 16 (ANI): US Vice President-elect Kamala Harris on Monday said that Joe Biden's administration would get COVID-19 under control in the country which has crossed the 11 million mark.
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Washington DC [US], November 16 (ANI): US President Donald Trump on Monday was quick to take credit as Moderna announced that its Covid-19 vaccine candidate has shown nearly 95 per cent efficacy.
Washington DC [US], November 16 (ANI): US President-elect Joe Biden on Monday said that the country is still "months away" from the COVID-19 vaccine, adding that Americans need to continue to practice social-distancing and mask-wearing to combat the virus.
Washington DC [US], November 16 (ANI): After the US biotech company Moderna on Monday announced significant interim results of its Covid-19 vaccine, the White House credited US President Donald Trump for the progress of the vaccine which has been shown to be 94.5 per cent effective for the t
Massachusetts [US], November 16 (ANI): US biotech company Moderna on Monday announced a new potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.
New Delhi [India], November 16 (ANI): External Affairs Minister (EAM) S Jaishankar on Monday stated that the world was counting on India to make COVID-19 vaccines accessible and affordable for all.
Caracas [Venezuela], November 16 (ANI/Sputnik): The supply of the Russian Sputnik V vaccine against COVID-19 to Venezuela is expected in January 2021, Venezuelan Vice President Delcy Rodriguez said.
Washington [US], November 15 (ANI): To suppress the impact of lung fibrosis, concerning COVID patients, scientists have been developing new treatment therapies, targeting the complications developed by the mutual relationship between the two.
Seoul [South Korea], November 15 (ANI): Features of the SARS-CoV-2 virus causing COVID-19, which could be useful for developing vaccines and treatment strategies, were identified using a nonhuman primate model developed at the Korea Research Institute of Bioscience and Biotechnology (KRIBB).
California [US], November 15 (ANI): La Jolla Institute for Immunology (LJI), has come up with a new breakthrough study, revealing the key to preventing asthma attacks by blocking two immune molecules at the same time is key to preventing asthma attacks in a mouse model.